CRS Scientist Spotlight on Dr. Alisha Ramos

Alisha Ramos, PhD, is a postdoctoral fellow in Dr. Francesca Duncan's lab. Her research focuses on a target-based drug screening approach to identify potential non-hormonal contraceptives for women. 

What brought you to join the CRS community, and what is your current position? 

I am a postdoctoral researcher in Dr. Francesca Duncan’s lab. I was drawn to the CRS community by my deep interest in advancing women’s health through cutting-edge reproductive research. The lab’s work on identifying non-hormonal contraceptive options, along with its broader focus on understanding female reproductive aging and fertility, resonated with my passion for addressing critical gaps in reproductive medicine. The opportunity to contribute to translational projects with real bench-to-bedside potential was especially compelling, as it allows me to bridge fundamental research with clinical applications that could directly benefit women's health.

Could you describe your research?

My research focuses on a target-based drug screening approach to identify potential non-hormonal contraceptives for women. I collaborate with an industry partner specializing in the design of small-molecule inhibitors, which I evaluate in relevant biological systems to assess their efficacy and safety. Through an iterative process, we work together to refine these inhibitors, optimizing their potency, selectivity, and biocompatibility to develop a viable contraceptive candidate.

What aspect of CRS do you find most valuable?

One of the most valuable aspects of CRS is its highly collaborative and interdisciplinary environment. The community brings together researchers, clinicians, and industry partners, fostering meaningful discussions and partnerships that drive innovation in reproductive science. It’s also incredible to be surrounded by so many reproductive scientists under one roof, all working toward a common goal of advancing reproductive health. I appreciate the emphasis on mentorship and professional development, which provides invaluable opportunities for growth at every career stage. Additionally, the diverse research within CRS, spanning from basic science to translational and clinical applications, creates a dynamic setting that continually inspires new ideas and advancements in the field.

What has been the most valuable aspect to your work in reproductive science?

Coming from a cancer biology background, transitioning into reproductive science could have been challenging, but the support and mentorship within the CRS community have made it an incredibly rewarding experience. My lab members and colleagues have been welcoming and eager to share their expertise, helping me navigate the field and build a strong foundation in reproductive research. I truly value the opportunity to learn from people at all levels—students, postdocs, professors, and my PI—each of whom brings unique insights that continuously shape and enhance my understanding of reproductive science.

What would you recommend to students and young professionals in order for them to succeed in their careers?

I would recommend staying curious, seeking out mentors, and embracing challenges as learning opportunities. Building a strong support network—whether through peers, mentors, or professional communities—can make a huge difference in personal and career growth. Don't be afraid to ask questions, take initiative, and step outside your comfort zone. Most importantly, don't be afraid to try something new, and don’t give up if something feels intimidating or doesn’t work out right away. Learning is a lifelong process, and persistence is key to growth and success. Stay humble and open to learning from everyone, regardless of their experience level or title—insight and knowledge can come from unexpected places.

What do you think will be the next big contribution in the reproductive biology field?

I’m rooting for non-hormonal contraception—whether for men or women—to be the next breakthrough in reproductive biology. Most available contraceptives rely on hormonal regulation, often causing side effects and leaving the burden of contraception largely on women. Developing a safe, effective, and reversible non-hormonal contraceptive would revolutionize reproductive health by providing more options for those who cannot or prefer not to use hormones. It would also promote shared contraceptive responsibility, a long-overdue shift in family planning. With advances in drug screening and target discovery, I believe we’re closer than ever to making this a reality.

What hobbies do you have outside of the lab?

Outside of the lab, I love exploring unique home decor and interior design ideas, always on the lookout for creative ways to personalize spaces. I also enjoy reading, rock climbing, and gardening—activities that help me unwind and stay active. I especially enjoy baking and cake decorating because they allow me to express my creativity.